Your Article Summary
Covidien Announces Reporting Changes
Covidien, 09/04/09
Covidien, a leading global provider of healthcare products, announced several financial reporting changes. The Specialty Chemicals business, previously reported in discontinued operations, has been reclassified to continuing operations within the Pharmaceuticals segment as a result of the Company’s decision to cease marketing the business for sale. The reclassification of this business to continuing operations will impact the Company’s results of operations and cash flows from continuing operations.
Today in Financial Reports...keeping you current
Receive free subspecialty "5-minute updates" via email
Report: Acquisition Activity Down
HealthDataManagement, 12/08/09
Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09
Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09
Article Search
Sponsor


See Latest Articles


